Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales39 87421 84820 24721 25222 51623 787
Operating income (EBITDA)12 6164 974-5 3405 9346 172
Operating profit (EBIT)9 8334 0464 3144 0174 4595 043
Pre-Tax Profit (EBT)6 2632 521----
Net income5 9632 5762 2842 9823 4033 809
EPS ( $)3,721,621,491,852,222,53
Dividend per Share ( $)1,670,64-0,931,091,19
Yield3,69%1,41%-2,05%2,40%2,63%
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt9 6743 086-1 7711 172-
Finance-----689
Operating income (EBITDA)12 6164 974-5 3405 9346 172
Leverage
(Debt/EBITDA)
0,77x0,62x-0,33x0,20x-
Capital Expenditure1 7951 145-1 0961 2321 275
Book Value Per Share (BVPS)17,0 $16,3 $-18,9 $20,3 $22,5 $
Cash Flow per Share5,85 $2,11 $-2,99 $3,23 $3,48 $
Announcement Date01/23/2013
12:47pm
01/22/2014
12:44pm
01/29/2015
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 68 152 M$ -
Entreprise Value (EV) 69 923 M$ 69 324 M$
Valuation 2015e 2016e
PER (Price / EPS) 24,4x 20,3x
Capitalization / Revenue 3,21x 3,03x
EV / Revenue 3,29x 3,08x
EV / EBITDA 13,1x 11,7x
Yield (DPS / Price) 2,05% 2,40%
Price to book (Price / BVPS) 2,39x 2,23x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 18,9% 19,8%
operating Leverage (Delta EBIT / Delta Sales) - 1,85x
Net Margin (Net Profit / Revenue) 14,0% 15,1%
ROA (Net Profit / Asset) 7,28% 8,00%
ROE (Net Profit / Equities) 12,7% 13,2%
Rate of Dividend 50,2% 48,8%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   5,16% 5,47%
Cash Flow / Sales (Taux d'autofinancement) 21,2% 21,6%
Capital Intensity (Assets / Sales) 1,93x 1,89x
Financial Leverage (Net Debt / EBITDA) 0,33x 0,20x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF